Gene Panel Market Forecasts to 2028 – Global Analysis By Technique (Amplicon-Based Approach and Hybridization-Based Approach), Product & Service (Testing Services and Test Kits), Sample Type, Design, Application, End User and By Geography
According to Stratistics MRC, the Global Gene Panel Market is accounted for $1.76 billion in 2020 and is expected to reach $7.98 billion by 2028 growing at a CAGR of 20.8% during the forecast period. The increasing prevalence of chronic diseases and the benefits of gene panels are the major factors propelling the market growth. However, issues related to the security of genetic data are hampering market growth.
Gene panel is a test that helps in analyzing multiple genes for cancer-associated mutations at once and consists of two genes – BRAC1 and BARC2 – that aid in the production of tumor-suppressing proteins that prevent the growth of tumor cells and help in repairing damaged DNA. This test aids in providing accurate information about cancer and diagnostics to prevent cancer from spreading.
Based on the design, the predesigned gene panel segment is estimated to have lucrative growth during the forecast period. Predesigned panels include important genes or gene regions that are associated with a disease or phenotype, selected from publications and expert guidance. Predesigned panels are convenient for research on various diseases, which include cancer, inherited disorders, and autism.
By geography, North America is going to have a huge demand during the forecast period. Factors such as the increasing prevalence of chronic and infectious diseases, cancer, the dominance of many leading key players and increasing support from governments for genomics research are boosting demand for gene panels in the region.
Some of the key players profiled in the Gene Panel Market include Novogene Corporation, Personalis, Inc., Gatc Biotech AG, Archerdx, Thermo Fisher Scientific Inc., Agilent, Qiagen, Eurofins Scientific SE, BGI, F. Hoffmann-La Roche AG, Integrated Dna Technologies, Genewiz, Inc., Illumina, Inc., GeneDx, and Centogene.
Estimated Market Size in 2020:
USD 1.76 billion
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
Tables, Graphs& Figures
Technique, Products & Service, Sample Type, Design, Technology Type, Application
End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Amplicon-Based Approach
• Hybridization-Based Approach
Products & Services Covered:
• Testing Services
• Test Kits
Sample Types Covered:
• Predesigned Gene Panel
• Customized Gene Panel
Technology Types Covered:
• Moist Heat Sterilization
• Dry Heat Sterilization
• Cancer Risk Assessment
• Diagnosis of Congenital Diseases
End Users Covered:
• Research and Academic Institutes
• Hospital and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Gene Panel Market is majorly driven by the increasing prevalence of chronic diseases, rising company initiatives, and the benefits of gene panels.
The customized gene panel segment is growing at the highest CAGR owing to evolving needs of the emerging therapeutic and diagnostic application sectors.
North America dominated with a significant market share owing to the increasing research on cancer and inherited rare diseases and rising number of NGS-based & clinical applications.
Asia Pacific market is growing at the highest CAGR due to an increase in health care awareness and a rise in demand for advanced medical technology.
Key players in Gene Panel Market include Novogene Corporation, Personalis, Inc., Gatc Biotech AG, Archerdx, Thermo Fisher Scientific Inc., Agilent, Qiagen, Eurofins Scientific SE, BGI, F. Hoffmann-La Roche AG, Integrated Dna Technologies, Genewiz, Inc., Illumina, Inc., GeneDx, and Centogene.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.